Medicina
Departamento
LUIS MIGUEL
RUILOPE URIOSTE
Investigador hasta 2008
Publicaciones en las que colabora con LUIS MIGUEL RUILOPE URIOSTE (80)
2023
-
Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 1
-
Twenty-four hour ambulatory blood pressure monitoring in patients with stable heart failure. Prevalence and associated factors
Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 852-861
2022
-
Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)
Hipertensión y riesgo vascular, Vol. 39, Núm. 4, pp. 174-194
-
IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE
Journal of hypertension, Vol. 40, pp. e81
-
The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
BMC Medicine, Vol. 20, Núm. 1
2021
-
Physical exercise and epicardial adipose tissue: A systematic review and meta-analysis of randomized controlled trials
Obesity Reviews, Vol. 22, Núm. 1
-
Response to Letter to the Editor
Obesity Reviews
2018
-
Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial
Hipertensión y riesgo vascular, Vol. 35, Núm. 3, pp. 119-129
2016
-
Aparato cardiovascular
Medimecum 2016: guía de terapia farmacológica ([Madrid] : Springer), pp. 289-406
2014
-
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial
Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897
-
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence
Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750
-
Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression
Journal of Hypertension, Vol. 32, Núm. 10, pp. 2082-2091
-
Documento de la sociedad española de nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica
Nefrologia, Vol. 34, Núm. 3, pp. 302-316
-
Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: Data of the Spanish ABPM registry
Journal of Hypertension, Vol. 32, Núm. 5, pp. 1016-1024
-
Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial
Revista Espanola de Cardiologia, Vol. 67, Núm. 11, pp. 881-882
2013
-
2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219
-
Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance
Journal of Hypertension, Vol. 31, Núm. 1, pp. 103-108
-
Comentario al manejo de la hipertensión resistente en una unidad multidisciplinaria de denervación renal: protocolo y resultados. Respuesta
Revista Espanola de Cardiologia
-
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus
JAMA Internal Medicine, Vol. 173, Núm. 18, pp. 1682-1692
-
Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension
Current Hypertension Reports, Vol. 15, Núm. 3, pp. 196-203